WebDec 21, 2016 · Zoetis Receives USDA License for CYTOPOINT™. First monoclonal antibody licensed to help control the clinical signs associated with atopic dermatitis in dogs. Targets and neutralizes interleukin-31 (IL-31), a key itch-inducing cytokine (protein) in canine atopic dermatitis. Provides convenience and long-lasting relief from itch with one ...
About Cytopoint® I Zoetis US
WebDec 21, 2024 · Cytopoint is a revolutionary new anti-itch therapy for symptomatic treatment of itch in dogs with allergies. This therapy provides an average of 4 weeks of itch relief and can be used in many dogs who cannot use other anti-itch treatments because of other medical conditions. Find out more about the benefits and drawbacks of this therapy. WebOct 29, 2024 · Cytopoint (lokivetmab) is a monoclonal antibody against the cytokine interleukin 31 (IL-31), a big player in the allergy inflammatory cascade. It is an injectable medication, administered under the skin. It takes effect quickly, relieving itch within 24 hours, and typically lasts anywhere from four to eight weeks. grass fed organic beef california
Cytopoint® Dosing & Administration I Zoetis US
WebCytopoint is the first and only caninized monoclonal antibody (mAb) treatment for dogs that specifically targets and neutralizes canine IL-31, with minimal impact on normal immune functions6,7 Together, we continue to change the way we approach allergic pruritus When to reach for Cytopoint or Apoquel® (oclacitinib tablet) One injection. WebFeb 28, 2024 · Cytopoint is a ready-to-use, sterile liquid containing a caninized monoclonal antibody (mAb) against interleukin-31 (IL-31). IL-31 has been shown to induce pruritus in dogs in laboratory studies. … WebCytopoint is a ready-to-use, sterile liquid containing a caninized monoclonal antibody (mAb) against interleukin-31 (IL-31). IL-31 has been shown to induce pruritus in dogs in … chittenden locks seattle